Transcription factor E2F1 is a protein that in humans is encoded by the E2F1gene.
The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis.
^Kong, Hee Jeong; Yu Hyun Jung; Hong SunHwa; Park Min Jung; Choi Young Hyun; An Won Gun; Lee Jae Woon; Cheong JaeHun (November 2003). "Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation". Mol. Cancer Res. (United States) 1 (13): 948–58. ISSN1541-7786. PMID14638867.
^Pardo, Patricia S; Leung James K, Lucchesi John C, Pereira-Smith Olivia M (December 2002). "MRG15, a novel chromodomain protein, is present in two distinct multiprotein complexes involved in transcriptional activation". J. Biol. Chem. (United States) 277 (52): 50860–6. doi:10.1074/jbc.M203839200. ISSN0021-9258. PMID12397079.Cite uses deprecated parameters (help)
^ abMarti, A; Wirbelauer C; Scheffner M; Krek W (May 1999). "Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation". Nat. Cell Biol. (ENGLAND) 1 (1): 14–9. doi:10.1038/8984. ISSN1465-7392. PMID10559858.
^Darbinian, N; Gallia G L; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K (November 1999). "Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1". Oncogene (ENGLAND) 18 (46): 6398–402. doi:10.1038/sj.onc.1203011. ISSN0950-9232. PMID10597240.
^Sansal, I; Dupont E; Toru D; Evrard C; Rouget P (October 2000). "NPDC-1, a regulator of neural cell proliferation and differentiation, interacts with E2F-1, reduces its binding to DNA and modulates its transcriptional activity". Oncogene (ENGLAND) 19 (43): 5000–9. doi:10.1038/sj.onc.1203843. ISSN0950-9232. PMID11042687.
^ abcdRotheneder, H; Geymayer S; Haidweger E (November 1999). "Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter". J. Mol. Biol. (ENGLAND) 293 (5): 1005–15. doi:10.1006/jmbi.1999.3213. ISSN0022-2836. PMID10547281.
^Yu, Xiaochun; Chini Claudia Christiano Silva; He Miao; Mer Georges; Chen Junjie (October 2003). "The BRCT domain is a phospho-protein binding domain". Science (United States) 302 (5645): 639–42. doi:10.1126/science.1088753. PMID14576433.
^Joshi, Bharat; Ko Danette, Ordonez-Ercan Dalia, Chellappan Srikumar P (December 2003). "A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis". Biochem. Biophys. Res. Commun. (United States) 312 (2): 459–66. doi:10.1016/j.bbrc.2003.10.148. ISSN0006-291X. PMID14637159.Cite uses deprecated parameters (help)
^Fusaro, Gina; Dasgupta Piyali; Rastogi Shipra; Joshi Bharat; Chellappan Srikumar (November 2003). "Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling". J. Biol. Chem. (United States) 278 (48): 47853–61. doi:10.1074/jbc.M305171200. ISSN0021-9258. PMID14500729.
^Kuwako, Ken-ichiro; Taniura Hideo; Yoshikawa Kazuaki (January 2004). "Necdin-related MAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor". J. Biol. Chem. (United States) 279 (3): 1703–12. doi:10.1074/jbc.M308454200. ISSN0021-9258. PMID14593116.
^Strachan, Gordon D; Jordan-Sciutto Kelly L, Rallapalli Ravikumar, Tuan Rocky S, Hall David J (February 2003). "The E2F-1 transcription factor is negatively regulated by its interaction with the MDMX protein". J. Cell. Biochem. (United States) 88 (3): 557–68. doi:10.1002/jcb.10318. ISSN0730-2312. PMID12532331.Cite uses deprecated parameters (help)
^Helin, K; Wu C L; Fattaey A R; Lees J A; Dynlacht B D; Ngwu C; Harlow E (October 1993). "Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation". Genes Dev. (UNITED STATES) 7 (10): 1850–61. doi:10.1101/gad.7.10.1850. ISSN0890-9369. PMID8405995.
^Zhou, Fangfang; Zhang Long; Wang Aijun; Song Bo; Gong Kai; Zhang Lihai; Hu Min; Zhang Xiufang; Zhao Nanming; Gong Yandao (May 2008). "The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation". J. Biol. Chem. (United States) 283 (21): 14506–15. doi:10.1074/jbc.M706136200. ISSN0021-9258. PMID18367454.
Dupont E, Sansal I, Toru D, et al. (1997). "[Identification of NPDC-1, gene involved in the control of proliferation and differentiation of neural and glial precursors]". C. R. Seances Soc. Biol. Fil.191 (1): 95–104. PMID9181131.
Zhang Z, Wang H, Li M, et al. (2006). "Novel MDM2 p53-independent functions identified through RNA silencing technologies.". Ann. N. Y. Acad. Sci.1058 (1): 205–14. doi:10.1196/annals.1359.030. PMID16394138.
Schild C, Wirth M, Reichert M, Schmid RM, Saur D, Schneider G (July 2009). "PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells". Mol. Carcinog.48 (12): 1149–58. doi:10.1002/mc.20569. PMID19603422.